Epigenetic drugs for Alzheimer's disease: hopes and challenges

Authors

  • Filippo Caraci,

    1. Department of Clinical and Molecular Biomedicine, Section of Pharmacology and Biochemistry, University of Catania, Catania, Italy
    2. Department of Educational Sciences, University of Catania, Catania, Italy
    Search for more papers by this author
  • Gian Marco Leggio,

    1. Department of Clinical and Molecular Biomedicine, Section of Pharmacology and Biochemistry, University of Catania, Catania, Italy
    Search for more papers by this author
  • Filippo Drago,

    1. Department of Clinical and Molecular Biomedicine, Section of Pharmacology and Biochemistry, University of Catania, Catania, Italy
    Search for more papers by this author
  • Salvatore Salomone

    Corresponding author
    • Department of Clinical and Molecular Biomedicine, Section of Pharmacology and Biochemistry, University of Catania, Catania, Italy
    Search for more papers by this author

  • Filippo Caraci is assistant professor of pharmacology (ricercatore), Gian Marco Leggio is instructor/researcher in pharmacology (assegnista di ricerca), Filippo Drago is full professor of pharmacology (professore ordinario), Salvatore Salomone is associate professor of pharmacology (professore associato)

CORRESPONDENCE

Dr Salvatore Salomone MD PhD, Department of Clinical and Molecular Biomedicine, Section of Pharmacology and Biochemistry, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy.

Tel.: +3909 5738 4085

Fax: +3909 5738 4238

E-mail: salomone@unict.it

No abstract is available for this article.

Ancillary